News — DEA

DEA Practitioners Manual - Part 13: Telemedicine

DEA Practitioners Manual: Telemedicine The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 significantly altered the landscape of telemedicine in the United States by adding provisions to the Controlled Substances Act (CSA) to prevent the illegal distribution and dispensing of controlled substances via the internet. The Act clarified several definitions and requirements for telemedicine practitioners, including the need for an "in-person medical evaluation" and what constitutes a "valid prescription." Here's a summary of the key components: Practice of Telemedicine: Defined as the practice of medicine via telecommunications by a practitioner who is remote from the patient, in compliance with...

Read more →

DEA Practitioner's Manual - Part 12: Summary of Prescriptions for Controlled Substances

Legitimate Medical Purpose A prescription for a controlled substance must be for a legitimate medical purpose and issued by a practitioner acting in their usual course of practice. Pharmacists have a corresponding responsibility to ensure the prescription's legitimacy. Who Can Issue a Prescription: According to 21 CFR 1306.03, a prescription can only be issued by: Practitioners authorized by their jurisdiction. Those registered with the DEA or exempt from registration. Agents or employees of registered institutions, provided specific additional requirements are met. What is a Prescription Per 21 CFR 1300.01(b), a prescription is an order for medication dispensed to an ultimate...

Read more →

DEA Practitioners Manual - Part 11: Security

Security measures that registered practitioners must take, as well as employment rules regarding individuals who have access to controlled substances. Let's break down some of the key points. DEA Security Requirements: Effective Controls: All registrants, including practitioners, must establish effective controls and procedures to prevent the theft and diversion of controlled substances. This is as per 21 CFR 1301.71(a). Storage: If controlled substances are kept in a DEA-registered office, they must be stored in a securely locked and substantially constructed cabinet, as per 21 CFR 1301.75(b). Employment Waivers: Restrictions: According to 21 CFR 1301.76(a), practitioners cannot employ individuals who have...

Read more →

DEA Practitioner’s Manual - Part 10: Schedule III-V Controlled Substances

DEA Practitioner’s Manual: Schedule III-V Controlled Substances Federal regulations in the United States governing the prescribing, dispensing, and refilling of Schedule II, III, IV, and V controlled substances according to the DEA Practitioner’s Manual and relevant parts of the Code of Federal Regulations (CFR) and United States Code (U.S.C.). For Schedule II substances: Written or electronic prescriptions are mandatory, with oral prescriptions permitted only in emergency situations. Refilling is prohibited. Multiple prescriptions are allowed up to a 90-day supply under certain conditions. Faxing a prescription is allowed, but the original must be verified. Emergency oral prescriptions have specific rules, including...

Read more →

DEA Practitioner's Manual - Part 9: Schedule II Controlled Substances

DEA Practitioner's Manual: Schedule II Controlled Substances Federal regulations and guidelines surrounding Schedule II controlled substances in the United States, covering topics like prescription requirements, refills, issuance of multiple prescriptions, facsimile prescriptions, emergency prescribing, and partial filling. These regulations are enforced by the Drug Enforcement Administration (DEA) and are meant to balance the need for access to these medications for legitimate medical use with the requirement to minimize the risk of abuse and diversion. The guidelines specify: Prescriptions must be written and signed by a qualified practitioner or meet DEA requirements for electronic prescriptions. Schedule II prescriptions can't be refilled....

Read more →